Related Experiment Videos
Renal medullary carcinoma
Muhammad Ahsan Baig1, Yu-Shia Lin, Javeria Rasheed
1Department of Internal Medicine and Division of Nephrology, Long Island College Hospital, Brooklyn, NY, USA. drahsanbaig@yahoo.com
Journal of the National Medical Association
|August 10, 2006
Summary
Renal medullary carcinoma is a rare cancer primarily affecting young Black patients with sickle cell trait. Early diagnosis is crucial for improving survival rates in this aggressive disease.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- Renal medullary carcinoma (RMC) is a rare and aggressive epithelial malignancy.
- RMC predominantly affects young Black individuals, particularly those with sickle cell hemoglobinopathies like sickle cell trait (SCT).
Observation:
- This case report details an African-American male diagnosed with RMC and sickle cell disease (HbSCD).
- The report outlines the distinct clinical, histological, and radiological characteristics of RMC.
Findings:
- Most RMC patients present with advanced, metastatic disease.
- Current treatment options for advanced RMC have shown limited success.
Implications:
- Shared demographic and clinical features between RMC and sickle cell disease necessitate increased awareness.
- Early detection of RMC is critical for potentially improving patient survival outcomes.